D N Manners1, G Rizzo2, C La Morgia3, C Tonon1, C Testa1, P Barboni4, E Malucelli5, M L Valentino3, L Caporali3, D Strobbe3, V Carelli6, R Lodi7. 1. From the Functional MR Unit (D.N.M., G.R., C.Tonon, C.Testa, R.L.). 2. From the Functional MR Unit (D.N.M., G.R., C.Tonon, C.Testa, R.L.) Neurology Unit (G.R., C.L.M., M.L.V., L.C., D.S., V.C.), Department of Biomedical and NeuroMotor Sciences. 3. Neurology Unit (G.R., C.L.M., M.L.V., L.C., D.S., V.C.), Department of Biomedical and NeuroMotor Sciences "Istituto di Ricovero e Cura a Carattere Scientifico Istituto delle Scienze Neurologiche di Bologna" (C.L.M., M.L.V., L.C., D.S., V.C.), Bologna, Italy. 4. Studio Oculistico d'Azeglio (P.B.), Bologna, Italy. 5. Department of Pharmacy and Biotechnology (E.M.), University of Bologna, Bologna, Italy. 6. Neurology Unit (G.R., C.L.M., M.L.V., L.C., D.S., V.C.), Department of Biomedical and NeuroMotor Sciences "Istituto di Ricovero e Cura a Carattere Scientifico Istituto delle Scienze Neurologiche di Bologna" (C.L.M., M.L.V., L.C., D.S., V.C.), Bologna, Italy raffaele.lodi@unibo.it valerio.carelli@unibo.it. 7. From the Functional MR Unit (D.N.M., G.R., C.Tonon, C.Testa, R.L.) raffaele.lodi@unibo.it valerio.carelli@unibo.it.
Abstract
BACKGROUND AND PURPOSE: Brain white matter is frequently affected in mitochondrial diseases; optic atrophy gene 1-autosomal dominant optic atrophy and Leber hereditary optic neuropathy are the most frequent mitochondrial monosymptomatic optic neuropathies. In this observational study, brain white matter microstructure was characterized by DTI in patients with optic atrophy gene 1-autosomal dominant optic atrophy and Leber hereditary optic neuropathy, in relation to clinical and genetic features. MATERIALS AND METHODS: Nineteen patients with optic atrophy gene 1-autosomal dominant optic atrophy and 17 with Leber hereditary optic neuropathy older than 18 years of age, all genetically diagnosed, and 19 healthy volunteers underwent DTI by using a 1.5T MR imaging scanner and neurologic and ophthalmologic assessments. Brain white matter DTI metrics were calculated for all participants, and, in patients, their correlations with genetics and clinical findings were calculated. RESULTS: Compared with controls, patients with optic atrophy gene 1-autosomal dominant optic atrophy had an increased mean diffusivity in 29.2% of voxels analyzed within major white matter tracts distributed throughout the brain, while fractional anisotropy was reduced in 30.3% of voxels. For patients with Leber hereditary optic neuropathy, the proportion of altered voxels was only 0.5% and 5.5%, respectively, of which half was found within the optic radiation and 3.5%, in the smaller acoustic radiation. In almost all regions, fractional anisotropy diminished with age in patients with optic atrophy gene 1-autosomal dominant optic atrophy and correlated with average retinal nerve fiber layer thickness in several areas. Mean diffusivity increased in those with a missense mutation. Patients with Leber hereditary optic neuropathy taking idebenone had slightly milder changes. CONCLUSIONS: Patients with Leber hereditary optic neuropathy had preferential involvement of the optic and acoustic radiations, consistent with trans-synaptic degeneration, whereas patients with optic atrophy gene 1-autosomal dominant optic atrophy presented with widespread involvement suggestive of a multisystemic, possibly a congenital/developmental, disorder. White matter changes in Leber hereditary optic neuropathy and optic atrophy gene 1-autosomal dominant optic atrophy may be exploitable as biomarkers.
BACKGROUND AND PURPOSE: Brain white matter is frequently affected in mitochondrial diseases; optic atrophy gene 1-autosomal dominant optic atrophy and Leber hereditary optic neuropathy are the most frequent mitochondrial monosymptomatic optic neuropathies. In this observational study, brain white matter microstructure was characterized by DTI in patients with optic atrophy gene 1-autosomal dominant optic atrophy and Leber hereditary optic neuropathy, in relation to clinical and genetic features. MATERIALS AND METHODS: Nineteen patients with optic atrophy gene 1-autosomal dominant optic atrophy and 17 with Leber hereditary optic neuropathy older than 18 years of age, all genetically diagnosed, and 19 healthy volunteers underwent DTI by using a 1.5T MR imaging scanner and neurologic and ophthalmologic assessments. Brain white matter DTI metrics were calculated for all participants, and, in patients, their correlations with genetics and clinical findings were calculated. RESULTS: Compared with controls, patients with optic atrophy gene 1-autosomal dominant optic atrophy had an increased mean diffusivity in 29.2% of voxels analyzed within major white matter tracts distributed throughout the brain, while fractional anisotropy was reduced in 30.3% of voxels. For patients with Leber hereditary optic neuropathy, the proportion of altered voxels was only 0.5% and 5.5%, respectively, of which half was found within the optic radiation and 3.5%, in the smaller acoustic radiation. In almost all regions, fractional anisotropy diminished with age in patients with optic atrophy gene 1-autosomal dominant optic atrophy and correlated with average retinal nerve fiber layer thickness in several areas. Mean diffusivity increased in those with a missense mutation. Patients with Leber hereditary optic neuropathy taking idebenone had slightly milder changes. CONCLUSIONS: Patients with Leber hereditary optic neuropathy had preferential involvement of the optic and acoustic radiations, consistent with trans-synaptic degeneration, whereas patients with optic atrophy gene 1-autosomal dominant optic atrophy presented with widespread involvement suggestive of a multisystemic, possibly a congenital/developmental, disorder. White matter changes in Leber hereditary optic neuropathy and optic atrophy gene 1-autosomal dominant optic atrophy may be exploitable as biomarkers.
Authors: Billy X Pan; Fred N Ross-Cisneros; Valerio Carelli; Kelly S Rue; Solange R Salomao; Milton N Moraes-Filho; Milton N Moraes; Adriana Berezovsky; Rubens Belfort; Alfredo A Sadun Journal: Invest Ophthalmol Vis Sci Date: 2012-11-09 Impact factor: 4.799
Authors: Michael Bach; Frederik B Laun; Alexander Leemans; Chantal M W Tax; Geert J Biessels; Bram Stieltjes; Klaus H Maier-Hein Journal: Neuroimage Date: 2014-06-16 Impact factor: 6.556
Authors: P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery Journal: Brain Date: 2010-02-15 Impact factor: 13.501
Authors: Gavin Hudson; Patrizia Amati-Bonneau; Emma L Blakely; Joanna D Stewart; Langping He; Andrew M Schaefer; Philip G Griffiths; Kati Ahlqvist; Anu Suomalainen; Pascal Reynier; Robert McFarland; Douglass M Turnbull; Patrick F Chinnery; Robert W Taylor Journal: Brain Date: 2007-12-07 Impact factor: 13.501
Authors: Maria Camilla Rossi-Espagnet; Martina Lucignani; Luca Pasquini; Antonio Napolitano; Stefano Pro; Andrea Romano; Daria Diodato; Diego Martinelli; Daniela Longo Journal: Neuroradiology Date: 2019-11-04 Impact factor: 2.804
Authors: S M Rueckriegel; G A Homola; M Hummel; N Willner; R-I Ernestus; C Matthies Journal: AJNR Am J Neuroradiol Date: 2016-06-02 Impact factor: 3.825
Authors: Ria de Haas; Devashish Das; Alejandro Garanto; Herma G Renkema; Rick Greupink; Petra van den Broek; Jeanne Pertijs; Rob W J Collin; Peter Willems; Julien Beyrath; Arend Heerschap; Frans G Russel; Jan A Smeitink Journal: Sci Rep Date: 2017-09-15 Impact factor: 4.379
Authors: Patrick Yu-Wai-Man; Achillefs Spyropoulos; Holly J Duncan; Joseph V Guadagno; Patrick F Chinnery Journal: Ann Clin Transl Neurol Date: 2016-07-19 Impact factor: 4.511